The Drug Enforcement Administration is accepting comments on a proposal to place the following substances, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, into schedule I of the Controlled Substances Act.

- N-(1-(2- fluorophenethyl)piperidin-4-yl)-N-(2-fluorophenyl)propionamide (2′-fluoro orthofluorofentanyl)

- N-(1-(4-methylphenethyl)piperidin-4-yl)-N-phenylacetamide (4′-methyl acetyl fentanyl)

- N-(1-phenethylpiperidin-4-yl)-N,3-diphenylpropanamide (β′-phenyl fentanyl; 3-phenylpropanoyl fentanyl)

- N-phenyl-N-(1-(2-phenylpropyl)piperidin-4- yl)propionamide (β-methyl fentanyl)

- N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4- yl)butyramide (ortho-fluorobutyryl fentanyl; 2-fluorobutyryl fentanyl)

- N-(2- methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide (ortho-methyl acetylfentanyl; 2- methyl acetylfentanyl)

- 2-methoxy-N-(2-methylphenyl)-N-(1-phenethylpiperidin-4- yl)acetamide (ortho-methyl methoxyacetylfentanyl)

- N-(4-methylphenyl)-N-(1- phenethylpiperidin-4-yl)propionamide (para-methylfentanyl; 4-methylfentanyl)

- N-(1- phenethylpiperidin-4-yl)-N-phenylbenzamide (phenyl fentanyl; benzoyl fentanyl)

- N-(1- phenethylpiperidin-4-yl)-N-phenylthiophene-2-carboxamide (thiofuranyl fentanyl)

This rule would impose the administrative, civil, and criminal sanctions and regulatory controls applicable to schedule I substances on the importation, exportation, manufacture, distribution, possession, research and conduct of instructional activities, and chemical analysis of these substances. Comments are due no later than April 2.

Copyright © 2024 Sandler, Travis & Rosenberg, P.A.; WorldTrade Interactive, Inc. All rights reserved.

ST&R: International Trade Law & Policy

Since 1977, we have set the standard for international trade lawyers and consultants, providing comprehensive and effective customs, import and export services to clients worldwide.

View Our Services 


Cookie Consent

We have updated our Privacy Policy relating to our use of cookies on our website and the sharing of information. By continuing to use our website or subscribe to our publications, you agree to the Privacy Policy and Terms & Conditions.